$KIDS

Squadron Capital LLC sold $6.4M of KIDS

Squadron Capital LLC sold 302,369 shares of ORTHOPEDIATRICS CORP (KIDS) at $21.01 ($6.35M total) on 2026-09-10. Filed jointly with Squadron Capital Holdings LLC (10% owner).

Original reporting
SEC EDGAR · Squadron Capital LLC, Squadron Capital Holdings LLC
Published Sep 11, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 1:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KIDS
Bearish
medium confidence
Mentioned
$KIDS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KIDSBearishMed
01

Why it matters

The insider's reduction of a 10% stake may be interpreted as a bearish signal, but could also reflect liquidity needs.

02

Market read

The filing is a primary source of material insider activity, relevant for short‑term traders monitoring KIDS.

03

What to watch

Potential tax‑loss harvesting or fund rebalancing could be driving the sale, not negative outlook.

Relevance 6/10Novelty 7/10Timing: post‑market 2026‑09‑10

Background

Form 4 filings provide the first public disclosure of insider transactions, offering timely insight into insider sentiment.

Company-level read

Ticker impact

$KIDSBearishMedium confidence
Context

Squadron Capital LLC sold 302,369 shares of Orthopedics Corp (KIDS) for $6.35M, reducing its stake to 6.2M shares.

Expected impact

Short-term downward pressure on KIDS as the market digests the insider sell.

Evidence & confidence

The sale size ($6.3M) is material for a mid‑cap stock and the insider holds a significant stake; such sales often precede price dips.

Market effects

May signal broader concerns in the orthopedics device sector if other insiders follow suit.

Limited to U.S. markets where KIDS trades.

Low; the event is company‑specific.

Counterpoint

The sale could be a routine portfolio adjustment unrelated to fundamentals, presenting a buying opportunity.

Key entities

  • Orthopedics Corp

    Medical device manufacturer listed on NASDAQ under ticker KIDS.

  • Squadron Capital LLC

    10% owner of Orthopedics Corp filing a Form 4 sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KIDSHighAI 8/10

OrthoPediatrics (KIDS) Crosses $70M as Guidance Climbs Higher

OrthoPediatrics (KIDS) reported Q2 revenue of $70.5M, up 15% YoY, and raised 2026 guidance to $265M-$269M. Trauma and Deformity revenue grew 26%, while international sales rose 22%. Despite higher expenses, gross margin expanded to 74% and adjusted EBITDA doubled to $6.8M. Net loss remained at $7.2M, and cash reserves declined to $47.9M.

$KIDSMed

OrthoPediatrics Corp. Q2 2026 Earnings Call Summary

OrthoPediatrics reported Q2 2026 progress toward a “financial inflection point,” citing record adjusted EBITDA margins near 10% and a shift toward positive free cash flow. Trauma and Deformity revenue grew 26% on implant share gains and early 3P Hip deployments. Management expects positive free cash flow in H2 2026 and FCF break-even or better for full-year 2026, with conservative timing assumptions for capital placements and international orders.